| Kenneth David Krause, MD | |
|
2600 S Parker Rd, #4-242, Aurora, CO 80014-1613 | |
| (303) 750-2082 | |
| (303) 750-6313 |
| Full Name | Kenneth David Krause |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 49 Years |
| Location | 2600 S Parker Rd, Aurora, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134290349 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 20384 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kenneth D Krause Md Pc | 1951389519 | 2 |
News Archive
Euro RSCG Worldwide PR (ERWW PR) announces the formation of its Health Buzz Group, a global division created in response to growing client interest in big, splashy "wows" from small budgets in quick time frames using traditional and social media to generate momentum.
At ages 1 and 1-1/2, children who get most of their sleep at night (as opposed to during the day) do better in a variety of skill areas than children who don't sleep as much at night.
Ontario is partnering with Baylis Medical Company, a leading supplier of cardiology and radiology products, to support an R&D expansion project at the company's Mississauga manufacturing plant.
PROLOR Biotech, Inc. today announced positive results from a preclinical toxicology study designed to assess the safety and tolerability of PROLOR's proprietary long-acting reversible-pegylation technology.
Scientists at the Helmholtz Zentrum München and the Ludwig Maximilians University of Munich have developed a new method of predicting disease progression in gliobastoma patients who have undergone standard treatment.
› Verified 8 days ago
| Entity Name | Kenneth D Krause Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023015435 PECOS PAC ID: 1951389519 Enrollment ID: O20040709001115 |
News Archive
Euro RSCG Worldwide PR (ERWW PR) announces the formation of its Health Buzz Group, a global division created in response to growing client interest in big, splashy "wows" from small budgets in quick time frames using traditional and social media to generate momentum.
At ages 1 and 1-1/2, children who get most of their sleep at night (as opposed to during the day) do better in a variety of skill areas than children who don't sleep as much at night.
Ontario is partnering with Baylis Medical Company, a leading supplier of cardiology and radiology products, to support an R&D expansion project at the company's Mississauga manufacturing plant.
PROLOR Biotech, Inc. today announced positive results from a preclinical toxicology study designed to assess the safety and tolerability of PROLOR's proprietary long-acting reversible-pegylation technology.
Scientists at the Helmholtz Zentrum München and the Ludwig Maximilians University of Munich have developed a new method of predicting disease progression in gliobastoma patients who have undergone standard treatment.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth David Krause, MD 2600 S Parker Rd, #4-242, Aurora, CO 80014-1613 Ph: (303) 750-2082 | Kenneth David Krause, MD 2600 S Parker Rd, #4-242, Aurora, CO 80014-1613 Ph: (303) 750-2082 |
News Archive
Euro RSCG Worldwide PR (ERWW PR) announces the formation of its Health Buzz Group, a global division created in response to growing client interest in big, splashy "wows" from small budgets in quick time frames using traditional and social media to generate momentum.
At ages 1 and 1-1/2, children who get most of their sleep at night (as opposed to during the day) do better in a variety of skill areas than children who don't sleep as much at night.
Ontario is partnering with Baylis Medical Company, a leading supplier of cardiology and radiology products, to support an R&D expansion project at the company's Mississauga manufacturing plant.
PROLOR Biotech, Inc. today announced positive results from a preclinical toxicology study designed to assess the safety and tolerability of PROLOR's proprietary long-acting reversible-pegylation technology.
Scientists at the Helmholtz Zentrum München and the Ludwig Maximilians University of Munich have developed a new method of predicting disease progression in gliobastoma patients who have undergone standard treatment.
› Verified 8 days ago
Lea C Watson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1890 N Revere Ct, Aurora, CO 80045 Phone: 720-848-0000 | |
Robert House, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Ann Olincy, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Paul Moe, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Erin Schwarz, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1537 Alton St, Aurora, CO 80010 Phone: 303-617-2300 | |
Robert Clyman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Bishara Bhasi, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |